Search

Search results

Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent To Be Superior To The Standard Of Care For Breakthrough Cancer Pain

... robust, high value pipeline of in-house products in pain, Parkinson's disease and critical care. It applies its world-class drug delivery ...

Article - Anna Ohlden - May 8 2009 - 2:00am - 0 attachments

Merck Serono Initiates SETTLE, The Second Phase III Clinical Trial Of Safinamide In Advanced Parkinson's Disease

... to a stable dose of levodopa, in mid- to late-stage Parkinson's disease patients with motor fluctuations compared to placebo. ... more than 450 patients with mid- to late-stage idiopathic Parkinson's disease (more than five years of disease duration) treated with a ...

Article - Anna Ohlden - May 7 2009 - 1:01am - 0 attachments

Raptor Pharmaceuticals Receives Notices Of Allowance For Two NeuroTrans(TM) Patent Applications

... including Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Multiple Sclerosis, and Amytrophic Lateral Sclerosis. We ...

Article - Anna Ohlden - Apr 29 2009 - 6:07am - 0 attachments

Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)

... robust, high value pipeline of in-house products in pain, Parkinson's disease and critical care. It applies its world-class drug delivery ...

Article - Anna Ohlden - Apr 29 2009 - 5:00am - 0 attachments

Boehringer Ingelheim Maintains Its Growth Path In 2008, Again Growing Faster Than The Pharmaceutical Market - Major Investments Once Again In Research And Development - Good Outlook For Further Growth In 2009

... and good tolerability in the symptomatic treatment of Parkinson's disease and the treatment of restless legs syndrome (RLS). ...

Article - Anna Ohlden - Apr 21 2009 - 8:00am - 0 attachments

Accera, Inc. Launches Neuera Pharmaceuticals, Inc.

... for hypometabolism, Neuera is developing drugs for Parkinson's disease, Huntington's disease, and other neurological conditions ...

Article - Anna Ohlden - Apr 15 2009 - 10:01am - 0 attachments

Some Parkinson's Medications Make Patients 'Hypersexual'

... patients receiving therapeutic doses of certain drugs for Parkinson's disease develops new-onset, potentially destructive behaviors, ... and ropinirole. They are commonly used to treat Parkinson's disease, but low doses also are used for restless legs syndrome. ...

Article - News Staff - Apr 8 2009 - 11:21am - 0 attachments

ProteoTech To Present At 9th International Conference For Alzheimer's And Parkinson's Disease - Prague, Czech Republic, March 11-15, 2009

... at the 9th International Conference for Alzheimer's and Parkinson's Diseases, to be held in Prague, Czech Republic, March 11-15, 2009. ... promising as a future disease-modifying treatment for Parkinson's disease and related disorders. ProteoTech's work in Parkinson's ...

Article - Anna Ohlden - Mar 9 2009 - 4:01pm - 0 attachments

Curcumin - Does This Indian 'Holy Powder' Ingredient Improve Cell Resistance To Infection?

... to be involved in type 2 diabetes, Alzheimer's disease, Parkinson's disease, and many other maladies. In addition, the researchers are ...

Article - News Staff - Mar 6 2009 - 11:30pm - 0 attachments

Another Breakthrough For Neural Adult Stem Cells

... These images show malfunctioning nerves consistent with Parkinson's. The second image (below) shows increasing activity after ... neural stem cell transplantation to reverse the effects of Parkinson's disease and demonstrated the long term safety and therapeutic ...

Article - Erin Richards - Feb 20 2009 - 12:41pm - 0 attachments